Novo Nordisk Community Care Supports Seattle Nonprofit Organizations in Fight Against Diabetes

Novo Nordisk Community Care Supports Seattle Nonprofit Organizations in Fight
                               Against Diabetes

Four local organizations make a significant impact in the community,
empowering residents living with type 2 diabetes

PR Newswire

SEATTLE, Dec. 12, 2013

SEATTLE, Dec. 12, 2013 /PRNewswire/ --Novo Nordisk announced it joined forces
with four Seattle nonprofit organizations to help stem the tide of type 2
diabetes at the local level and help support programs that will educate and
empower local residents to better manage their diabetes. All four
organizations support the well-being of patients in the Seattle community and
provide overall health-related guidance and resources through their
cutting-edge programs.

  oCenter for MultiCultural Health, a local center focused on promoting the
    health and well-being of diverse communities, will launch their new "Let's
    Talk About It: A Conversation About Diabetes Among African Americans"
    program, which includes a digital stories series and a corresponding
    discussion guide
  oEvergreenHealth Foundation, which supports the EvergreenHealth community
    health system, will implement two 9-week lifestyle change programs titled
    "Kickstarter 9 to Health," which will integrate lifestyle changes, healthy
    eating and nutrition changes to empower patients living with type 2
    diabetes to attain lasting, meaningful change. The programs will each
    culminate with a 5K community walk
  oSenior Services, a volunteer-supported agency committed to providing vital
    assistance to older adults in Seattle and King County, will train Sea Mar
    Community Medical Clinic healthcare providers in diabetes education to
    provide on-site health promotion and disease management services to
    Hispanic and Latino elders with type 2 diabetes in the community
  oUniversity of Washington Foundation, which aims to advance the mission of
    the University of Washington, will launch a new program that will help
    patients from Harborview Medical Center with self-management and type 2
    diabetes education after they've been discharged from the Center

All four local organizations' programs were selected as part of the Novo
Nordisk Community Care initiative, which provides funding to nonprofit
organizations across the country to support educational programs that empower
people living with type 2 diabetes to take control of their health and,
ultimately, help prevent long-term complications. The groups were selected
because their proposed programs are sustainable, impactful and educational,
and took an innovative approach to addressing type 2 diabetes.

"Diabetes has become a national health crisis and is taking a major toll on
local communities, including Seattle" said Diana Blankman, Senior Director,
U.S. Corporate Giving and Social Impact at Novo Nordisk. "In Washington State,
approximately 1.7 million people are in danger of developing diabetes by 2015.
Novo Nordisk recognizes the critical role these local organizations play in
addressing the health crisis and are committed to helping them address this
crisis on the local level."

According to data commissioned by Novo Nordisk from the Institute of
Alternative Futures, by 2015 Washington is estimated to have approximately
678,000 people with diagnosed and undiagnosed diabetes. This could result in a
total of $6.5 billion in total medical and indirect societal costs of diabetes
for the state of Washington by 2015.

In addition to Seattle, Novo Nordisk is awarding Community Care sponsorships
to nonprofit groups in Portland, Oregon, and Rochester, Minnesota, where
diabetes is a heavy burden on the communities. Since the inception of the
Community Care program in 2011, Novo Nordisk has supported nearly 40 local
diabetes nonprofit organizations in 11 local communities that are making an
impact on type 2 diabetes. For more information about the program, visit

About Novo Nordisk

Headquartered in Denmark, Novo Nordisk is a global health care company with 90
years of innovation and leadership in diabetes care. The company also has
leading positions within hemophilia care, growth hormone therapy and hormone
therapy. For more information, visit novonordisk-us.comor follow US
activities on Twitter at @novonordiskus.

SOURCE Novo Nordisk

Contact: Michelle Powell, 609-786-8598,
Press spacebar to pause and continue. Press esc to stop.